Ottawa, Feb 18 (SocialNews.XYZ) Health Canada announced that it has authorized the use of Moderna's Spikevax bivalent Covid-19 booster vaccine for children and adolescents aged six to 17 years of age targeting the Omicron variant BA.1.
A booster dose of 50 micrograms may be administered in individuals 12 years of age and older at least 4 months after completing their primary vaccine series or a previous booster dose and a booster dose of 25 micrograms in children 6 to 11 years of age at least 6 months after completing their primary vaccine series or a previous booster dose, Xinhua news agency quoted the health body as saying.
"The authorization of a booster dose in children and adolescents is a critical step to broaden protection against the Omicron family of variants, and the emergence of new variants of concern in Canada," said Stephane Bancel, chief executive officer of Moderna, in a news release.
The BA.1 booster was previously approved for people aged 18 and over.
Moderna's Omicron-targeting bivalent booster for variant BA.4/5 has not yet been approved for use in people under 18 years of age.
Source: IANS
About Gopi
Gopi Adusumilli is a Programmer. He is the editor of SocialNews.XYZ and President of AGK Fire Inc.
He enjoys designing websites, developing mobile applications and publishing news articles on current events from various authenticated news sources.
When it comes to writing he likes to write about current world politics and Indian Movies. His future plans include developing SocialNews.XYZ into a News website that has no bias or judgment towards any.
He can be reached at gopi@socialnews.xyz